- Home
- MPV vs SCPH Comparison
MPV vs SCPH Comparison
Compare MPV & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPV
- SCPH
- Stock Information
- Founded
- MPV 1988
- SCPH 2013
- Country
- MPV United States
- SCPH United States
- Employees
- MPV N/A
- SCPH N/A
- Industry
- MPV Finance Companies
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- MPV Finance
- SCPH Health Care
- Exchange
- MPV Nasdaq
- SCPH Nasdaq
- Market Cap
- MPV 201.1M
- SCPH 299.0M
- IPO Year
- MPV N/A
- SCPH 2017
- Fundamental
- Price
- MPV $20.38
- SCPH $5.62
- Analyst Decision
- MPV
- SCPH Buy
- Analyst Count
- MPV 0
- SCPH 3
- Target Price
- MPV N/A
- SCPH $12.00
- AVG Volume (30 Days)
- MPV 25.2K
- SCPH 2.4M
- Earning Date
- MPV 01-01-0001
- SCPH 11-12-2025
- Dividend Yield
- MPV 8.71%
- SCPH N/A
- EPS Growth
- MPV N/A
- SCPH N/A
- EPS
- MPV 1.71
- SCPH N/A
- Revenue
- MPV N/A
- SCPH $49,969,000.00
- Revenue This Year
- MPV N/A
- SCPH $104.30
- Revenue Next Year
- MPV N/A
- SCPH $76.06
- P/E Ratio
- MPV $9.35
- SCPH N/A
- Revenue Growth
- MPV N/A
- SCPH 107.79
- 52 Week Low
- MPV $11.18
- SCPH $1.94
- 52 Week High
- MPV $16.42
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- MPV 61.79
- SCPH 63.32
- Support Level
- MPV $20.13
- SCPH $4.33
- Resistance Level
- MPV $20.46
- SCPH $5.62
- Average True Range (ATR)
- MPV 0.35
- SCPH 0.04
- MACD
- MPV 0.04
- SCPH -0.01
- Stochastic Oscillator
- MPV 94.12
- SCPH 80.00
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.